120 related articles for article (PubMed ID: 36921732)
1. Remarkable 107-year-old kidney with a 49-year of long-term allograph survival through continuous azathioprine monotherapy.
Nascimento E; Filho AS; Lucas-Junior FDM; Jobim LFJ; Lasmar MF; Tavares-Filho HA; Fabreti-Oliveira RA
Transpl Immunol; 2023 Jun; 78():101821. PubMed ID: 36921732
[TBL] [Abstract][Full Text] [Related]
2. Kidney Transplantation With Ultralong-Term (42 Years) Survival of a 100-Year-Old Graft.
Nascimento E; Lucas-Junior FM; Fabreti-Oliveira RA; Vilela B; Tavora ER; Silva JP; Salomão-Filho A
Transplant Proc; 2016 Nov; 48(9):3079-3084. PubMed ID: 27932151
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation.
Verghese PS; Dunn TB; Chinnakotla S; Gillingham KJ; Matas AJ; Mauer MS
Nephrol Dial Transplant; 2014 Jan; 29(1):209-18. PubMed ID: 24414376
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
[TBL] [Abstract][Full Text] [Related]
6. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
Zeng Y; Liu Z; Liu Y; Fan Y; Guo Y; Qiu J
Urol Int; 2014; 92(3):328-33. PubMed ID: 24480999
[TBL] [Abstract][Full Text] [Related]
7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
8. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
9. Effect of donor-to-recipient HLA matching in low-immunological risk kidney transplant recipients without induction therapy on acute rejection, graft survival, infections, and surgical complications at 3 years: The road towards new recommendations.
Abou-Jaoudé M; El Hage S; Akiki D; Araman R
Transpl Immunol; 2021 Dec; 69():101490. PubMed ID: 34695578
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of pretransplantation microchimerism on rejection-free survival in HLA-haploidentical family donor renal transplantation.
Joo SY; Song EY; Shin Y; Ha J; Kim SJ; Park MH
Transplantation; 2013 Jun; 95(11):1375-82. PubMed ID: 23519024
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival.
Mărunţelu I; Nistor CE; Cristea BM; Rotarescu CA; Caragea AM; Tizu M; Constantinescu I
Ann Transplant; 2022 Aug; 27():e937267. PubMed ID: 35957504
[TBL] [Abstract][Full Text] [Related]
12. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
[TBL] [Abstract][Full Text] [Related]
13. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe).
Ponticelli C; Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Mastrangelo F; Castagneto M; Salvadori M; Valente U; Cossu M; Federico S; Pisani F; Montagnino G; Messina M; Arisi L; Carmellini M; Piredda G; Corbetta G
J Am Soc Nephrol; 1997 Apr; 8(4):638-46. PubMed ID: 10495794
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.
Oliveira JG; Monteiro MS; Teixeira JF; Osório E; Norton SM; Alves H; Pestana M
Transpl Int; 2005 Nov; 18(11):1286-91. PubMed ID: 16221160
[TBL] [Abstract][Full Text] [Related]
15. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Mycophenolate Mofetil Acute Renal Rejection Study Group
Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine vs cyclosporine in recipients of HLA-identical renal allografts.
Gill IS; Hodge EE; Novick AC; Streem SB; Braun WE; Paranandi L
Cleve Clin J Med; 1994; 61(3):206-10. PubMed ID: 8026064
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
